Fall-Related Injury

A post hoc analysis of five randomized controlled trials suggests that older adults with osteoporosis assigned denosumab therapy were 20% less likely to experience a fall during follow-up compared with those assigned placebo, according to findings published in the Journal of Bone and Mineral Research.